NCT06371417
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) No drug interventions treatment 1 recruiting NCT01151644
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases No drug interventions prevention 4 unknown_status NCT04723303
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) No drug interventions treatment 0 completed NCT04044690
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) treatment 3 active_not_recruiting NCT00001421
Methimazole to Treat Polymyositis and Dermatomyositis treatment 2 completed NCT05495321
Interleukin-2 on Active Dermatomyositis treatment 3 enrolling_by_invitation NCT05239702
Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases No drug interventions treatment 0 recruiting NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity No drug interventions Not Available Not Available completed NCT00106184
Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) treatment 2 completed NCT00341679
Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases No drug interventions Not Available Not Available completed NCT03267277
Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis treatment 2 / 3 completed NCT02971683
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy treatment 3 completed NCT04486261
High-intensity Strength Training in Myositis No drug interventions treatment Not Available completed NCT05833711
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy treatment 2 recruiting NCT03181893
A Study In Adults With Moderate To Severe Dermatomyositis treatment 2 completed NCT00005571
Safety and Effectiveness of h5G1.1-mAb for Dermatomyositis treatment 2 completed NCT00112385
A Pilot Study of Etanercept in Dermatomyositis treatment 1 completed NCT04747652
Clinical Research on Advanced Warning Factors Of Respiratory Injury in Dermatomyositis No drug interventions Not Available Not Available unknown_status NCT06154252
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy treatment 1 / 2 recruiting NCT05027152
Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties No drug interventions treatment Not Available unknown_status NCT01276470
Environmental Risk Factors for the Anti-synthetase Syndrome No drug interventions Not Available Not Available recruiting NCT04628936
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. treatment 2 completed NCT01432613
Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies No drug interventions diagnostic Not Available completed NCT06347718
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease No drug interventions treatment 1 / 2 recruiting NCT06298019
Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis No drug interventions treatment 1 not_yet_recruiting NCT01813617
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis Not Available Not Available completed NCT06004817
Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis No drug interventions Not Available Not Available recruiting NCT05832034
Add-on Intravenous Immunoglobulins in Early Myositis treatment 2 recruiting NCT00035958
Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis treatment 2 / 3 terminated NCT02594735
Abatacept in Juvenile Dermatomyositis treatment 4 completed NCT05437263
A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis No drug interventions treatment 3 active_not_recruiting NCT06149039
Study on Lymphocyte Subsets of Peripheral Blood in Patients With Nonmyopathic Dermatomyositis Complicated With Pulmonary Interstitial Disease No drug interventions Not Available Not Available recruiting NCT00866125
Hand Function in Patients With Poly- or Dermatomyositis No drug interventions Not Available Not Available completed NCT02043548
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis treatment 2 completed NCT00004357
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis treatment 2 completed NCT03027674
Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud treatment 0 completed NCT02418273
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders treatment 1 / 2 withdrawn NCT03813160
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis treatment 3 completed NCT04972760
Baricitinib in Patients With Relapsing or naïve Dermatomyositis treatment 3 recruiting NCT03981744
A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments treatment 3 terminated NCT04976140
Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis No drug interventions treatment 1 / 2 completed NCT06462768
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis No drug interventions Not Available Not Available recruiting NCT01734369
Environmental Risk Factors for Myositis in Military Personnel No drug interventions Not Available Not Available completed NCT05695950
A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis No drug interventions treatment 2 recruiting NCT01165008
Anakinra in Myositis treatment 2 / 3 completed NCT02466243
Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis treatment 2 terminated NCT01140503
A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis treatment Not Available terminated NCT01637064
Dermatomyositis and Polymyositis Registry Not Available Not Available unknown_status NCT06056921
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease No drug interventions treatment 1 recruiting NCT06438679
3T Therapy in the Treatment of MDA5-positive Dermatomyositis treatment 4 enrolling_by_invitation NCT06284954
A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults with Dermatomyositis treatment 2 recruiting NCT02945345
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) No drug interventions Not Available Not Available recruiting NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer treatment 1 recruiting NCT02980198
Study of IFN-K in Dermatomyositis No drug interventions treatment 2 withdrawn NCT00001261
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies No drug interventions treatment 2 completed NCT03840928
PatientSpot Formerly Known as ArthritisPower No drug interventions Not Available Not Available recruiting NCT05361109
Baricitinib for Cutaneous Dermatomyositis treatment 2 withdrawn NCT00335985
Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) treatment 3 completed NCT03293615
Exercise Capacity of Patients With Dermatomyosis No drug interventions prevention Not Available recruiting NCT02728752
Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) treatment 3 completed NCT03324152
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis No drug interventions treatment Not Available unknown_status NCT05192200
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study treatment 2 completed NCT03582800
Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study No drug interventions treatment 2 recruiting NCT06433999
A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis No drug interventions treatment 2 not_yet_recruiting NCT03002649
Study of Tofacitinib in Refractory Dermatomyositis treatment 1 completed NCT01415219
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis No drug interventions treatment 2 completed NCT02245841
Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis treatment 4 completed NCT05979441
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy No drug interventions treatment 3 enrolling_by_invitation NCT03817424
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis treatment 1 completed NCT00010335
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders No drug interventions treatment 1 completed NCT03414086
Predictor of Clinical Response to Acthar in Myositis No drug interventions Not Available Not Available completed NCT04402086
Rheumatology Patient Registry and Biorepository No drug interventions Not Available Not Available recruiting NCT00504348
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus treatment 2 / 3 completed NCT02612857
Trial of IMO-8400 in Adult Patients With Dermatomyositis treatment 2 completed NCT03192657
Basiliximab Treating Interstitial Pneumonia of CADM treatment 2 unknown_status NCT04033926
A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis treatment 2 completed NCT00001265
Study and Treatment of Inflammatory Muscle Diseases No drug interventions Not Available Not Available completed NCT02271165
Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study treatment 0 terminated NCT04999020
Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis treatment 2 / 3 terminated NCT05637931
Plexin D1 as a Potential Biomarker inPM/DM No drug interventions Not Available Not Available not_yet_recruiting NCT00001331
Genetic and Family Studies of Inherited Muscle Diseases No drug interventions Not Available Not Available completed NCT02880527
Study of the Prevalence of Polymyositis and Dermatomyositis in Normandy No drug interventions Not Available Not Available completed NCT05488327
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis treatment Not Available unknown_status NCT00033891
Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis treatment 2 completed NCT00213629
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies No drug interventions diagnostic Not Available completed NCT00651040
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM treatment 3 completed NCT05523167
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy. No drug interventions treatment 2 / 3 recruiting NCT05650567
Study of M5049 in DM and PM Participants (NEPTUNIA) treatment 2 recruiting NCT01906372
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis treatment 2 completed NCT04946669
An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis treatment 0 unknown_status NCT03686969
Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis treatment 3 terminated NCT01148810
Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis treatment 2 terminated NCT00017914
Adult and Juvenile Myositis No drug interventions Not Available Not Available recruiting NCT06002750
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation No drug interventions Not Available Not Available completed NCT01315938
Abatacept Treatment in Polymyositis and Dermatomyositis treatment 2 completed